ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

1,3-Cyclopentadiene, 5-(1-methylethylidene)- → (Cyclopentadienyl)-[(2,7-di-phenyl-3,6-di-tert-butylfluorenyl)]-propane

HRID 420025
印刷

反応式

HRID 420025 の反応式
[CH2:1]([Li])CCC.[C:6]1([C:12]2[C:24]([C:25]([CH3:28])([CH3:27])[CH3:26])=[CH:23][C:22]3[C:21]4[C:16](=[CH:17][C:18]([C:33]5[CH:38]=[CH:37][CH:36]=[CH:35][CH:34]=5)=[C:19]([C:29]([CH3:32])([CH3:31])[CH3:30])[CH:20]=4)[CH2:15][C:14]=3[CH:13]=2)[CH:11]=[CH:10][CH:9]=[CH:8][CH:7]=1.C[C:40]([CH3:46])=[C:41]1[CH:45]=[CH:44][CH:43]=[CH:42]1>C1COCC1.CCOCC>[CH:41]1([CH:40]([C:13]2[C:14]3[CH2:15][C:16]4[C:21](=[CH:20][C:19]([C:29]([CH3:31])([CH3:32])[CH3:30])=[C:18]([C:33]5[CH:34]=[CH:35][CH:36]=[CH:37][CH:38]=5)[CH:17]=4)[C:22]=3[CH:23]=[C:24]([C:25]([CH3:26])([CH3:27])[CH3:28])[C:12]=2[C:6]2[CH:11]=[CH:10][CH:9]=[CH:8][CH:7]=2)[CH2:46][CH3:1])[CH:42]=[CH:43][CH:44]=[CH:45]1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 3

HCID 1374671,3-Cyclopentadiene, 5-(1-methylethylidene)-HCID 219826953,6-DI-Tert-butyl-2,7-diphenyl-9H-fluoreneHCID 178418339Butyllithium

生成物 1

HCID 131726780(Cyclopentadienyl)-[(2,7-di-phenyl-3,6-di-tert-butylfluorenyl)]-propane

試薬・触媒・溶媒 2

HCID 3283Diethyl Ether溶媒
HCID 8028
Tetrahydrofuran
溶媒

実験手順

Butyllithium (1.5 ml, 1.6M in hexane, 2.40 mmol) was added to 2,7-diphenyl-3,6-di-t-butyl-fluorene (0.95 g, 2.20 mmol) in THF (20 ml) at −78° C. The reaction mixture was allowed to warm to room temperature and stirred for 2.5 hours. The solvent was removed under vacuum. Ether (5 ml) was added and removed under vacuum. Ether (25 ml) was added and 6,6′-dimethylfulvene (0.23 g, 2.43 mmol) in ether (5 ml) was added to the reaction mixture at 0° C. The reaction was stirred at room temperature for 5 days. The reaction mixture was quenched with water, extracted with ether, dried over MgSO4, and evaporated under vacuum to afford the residue which was purified by column chromatography (silica gel, hexane/CH2Cl2=5/1) and crystallized from hot hexane. The yield was 0.40 g, 34%. 1H NMR (CDCl3): δ 7.91 and 7.30 (each s, 2H, 1,8- and 4,5-H (Flu), 7.35 (m, 10H, Ph), 6.76, 6.40 (m, 3H, Cp), 4.04 and 4.02 (s 2H, H9), 3.00 and 2.78 (br s, 2H, CH2 Cp), 1.31 (s, 18H, t-Bu), 1.11 and 1.09 (s, 6H, Me). 1H NMR (CD2Cl2): δ 7.91 and 7.29 (each s, 2H, 1,8- and 4,5-H (Flu), 7.2-7.4 (m, 10H, Ph), 6.8-6.7, 6.40 (m, 3H, Cp), 4.02 (brs, 2H, H9), 3.00 and 2.78 (br s, 2H, CH2 Cp), 1.28 (s, 18H, t-Bu), 1.07 and 1.04 (s, 6H, Me). HPLC: 10.38 and 10.65 min.

後処理

  1. customThe solvent was removed under vacuum
  2. additionEther (5 ml) was added
  3. customremoved under vacuum
  4. additionEther (25 ml) was added
  5. stirringThe reaction was stirred at room temperature for 5 days
  6. customThe reaction mixture was quenched with water
  7. extractionextracted with ether
  8. dry with materialdried over MgSO4
  9. customevaporated under vacuum
  10. customto afford the residue which
  11. customwas purified by column chromatography (silica gel, hexane/CH2Cl2=5/1)
  12. customcrystallized from hot hexane
  13. custom10.38 and 10.65 min.

出典と根拠

ORDレコード
ord-97acc016e3884f66bfc9c75bf2b3e773
出典データセット
uspto-grants-2012_01
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08093418B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート